SMP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SMP is not a good buy right now for an impatient buyer. The chart is mildly bullish, but price is sitting just below near-term resistance (~40.39) with no proprietary buy signals, no options-volume confirmation, no fresh news catalysts, and the last reported quarter showed a swing to a loss despite strong revenue growth. With earnings coming 2026-02-23 (pre-market), risk/reward for an immediate entry is not compelling; I’d rate it a HOLD rather than a buy at 39.77.
Trend/structure: Bullish moving-average stack (SMA_5 > SMA_20 > SMA_200) suggests an uptrend/basing phase is intact. Momentum: MACD histogram is positive (0.082) but contracting, implying upside momentum is weakening rather than accelerating. RSI(6)=58 is neutral-to-slightly-bullish (no overbought/oversold edge). Levels: Pivot 39.399 is the key line—price (39.77) is slightly above it. Immediate resistance is R1 40.388 (then R2 40.999). Support sits at S1 38.409 (then S2 37.798). Practical read: the stock looks fine technically, but it’s not offering a strong “buy-now” setup unless it can clear ~40.39 decisively; otherwise it’s prone to chop/pullback toward 38.41.
Intellectia Proprietary Trading Signals Intellectia Proprietary Trading Signals
Technicals remain constructive (bullish MA alignment), so a clean break above ~40.39–41.00 could attract momentum buyers.
Revenue growth is strong in the latest quarter (2025/Q3 +24.94% YoY) and gross margin improved (+6.68% YoY), which could support a rebound narrative if profitability stabilizes.
Upcoming earnings on 2026-02-23 (pre-market) can act as an upside catalyst if EPS and forward commentary beat expectations.
Profitability deterioration: 2025/Q3 net income turned negative (-$4.335M) and EPS was -0.20, a sharp decline YoY—this is the biggest fundamental overhang.
No supportive near-term news flow (no news in the last week) and no notable hedge-fund/insider accumulation signals (both neutral).
Options positioning is slightly defensive (OI put/call >
and IV is high, implying the market expects meaningful movement/risk.
Pattern-based projection is weak: similar-pattern stats point to slightly negative drift over the next week/month (approx. -0.24% next week, -3.4% next month).
Latest quarter: 2025/Q3. Revenue rose to $498.836M (+24.94% YoY), and gross margin improved to 32.43 (+6.68% YoY), which is constructive on the top line and profitability at the gross level. However, the bottom line weakened significantly: net income fell to -$4.335M (-213.78% YoY) and EPS dropped to -0.20 (-217.65% YoY). Net losses despite higher revenue indicate higher operating costs/other expenses are pressuring results; until that reverses, the stock lacks a clean fundamental “buy now” profile ahead of earnings.
No analyst rating/price target trend data was provided, so I can’t confirm whether Wall Street has been upgrading or cutting targets recently. Based strictly on the data here, the bull case would focus on strong revenue growth + improved gross margin + constructive technical trend; the bear case focuses on the swing to a quarterly loss, elevated implied volatility into earnings, and the lack of clear institutional/insider conviction signals. Politician/congress activity: no recent congress trading data available (no identified influential-figure buys/sells in the provided dataset).
